Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-22

Clinical Trial Update: Study of the Absorption of Vitamin E Water-soluble Form (Pegylated) in the Familial Hypocholesterolemia With Chylomicron Retention [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 study assessing the absorption of a pegylated, water-soluble form of Vitamin E in individuals with familial hypobe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pegylated water-soluble Vitamin E (tocopherol polyethylene glycol)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Hypobetalipoproteinemias | Phase 3 | Status: COMPLETED